Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy (Q72630680)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

progressive myoclonus epilepsy

28 October 2019

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

18 August 2023

author name string

E. Leino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6163302

18 August 2023

E. MacDonald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6163302

18 August 2023

M. M. Airaksinen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6163302

18 August 2023

P. J. Riekkinen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6163302

18 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6163302

18 August 2023

publication date

1 July 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0404.1980.tb03002.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1980.tb03002.x/fullpdf

18 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Acta Neurologica Scandinavica

18 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

41-54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

Myoclonus. Clinical significance and an approach to classification

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Uptake of Taurine, GAB A, 5-HT, and Dopamine by Blood Platelets in Progressive Myoclonus Epilepsy

18 August 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine

18 August 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Origin of 5-Hydroxyindoleacetic Acid in the Spinal Fluid

18 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Manipulation of brain serotonin in the treatment of myoclonus

18 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam

18 August 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs

18 August 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Manipulation of Cerebral Monoamines in the Treatment of Human Epilepsy: A Pilot Study

18 August 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Distribution of valproate across the interface between blood and cerebrospinal fluid

18 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent

18 August 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus

18 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy

18 August 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Findings in routine laboratory examination in progressive myoclonus epilepsy

18 August 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Psychological findings in progressive myoclonus epilepsy without Lafora bodies.

18 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Familial essential myoclonus.

18 August 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Amine metabolism in the human brain: Further evaluation of the probenecid test

18 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy.

18 August 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients

18 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Labelled 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid Formed in Vivo from ‘H-Tryptophan in Rat Brain; Effect of Probenecid*)

18 August 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy

18 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Uptake of 5-HT by blood platelets of patients with myoclonus epilepsy

18 August 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

18 August 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0404.1980.TB03002.X

18 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6163302%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference